Related Experiment Video
Updated: Jul 2, 2026

Enhanced Spatial Mapping of Mouse Gastric Muscle Layers Using a Modified Swiss Roll Technique
Published on: November 25, 2025
Upregulation of GADD153 by butyrate: involvement of MAPK
David W Scott1, Jennifer M Longpre, George Loo
1Department of Nutrition, Cellular and Molecular Nutrition Research Laboratory, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170, USA.
Abstract:
Butyrate inhibits the proliferation of cancer cells, but the early molecular events initiated by butyrate have not been fully identified. Herein, butyrate is shown to affect the growth arrest and DNA damage-inducible gene 153 (GADD153) in HCT-116 human colon adenocarcinoma cells. Despite absence of any detectable cellular DNA damage, the expression of GADD153 was upregulated before several features characteristic of apoptosis appeared. Butyrate-induced upregulation of GADD153 mRNA was attenuated by actinomycin D, but apparently not by cycloheximide. In investigating possible involvement of MAPK in mediating the effect of butyrate on GADD153 mRNA expression, the extracellular regulated kinase (ERK) inhibitor PD98059, but neither the JNK inhibitor SP600125 nor the p38 MAPK inhibitor SB203580, blunted the ability of butyrate to upregulate GADD153 mRNA expression. U0126, a selective inhibitor of upstream MEK, had a similar effect as PD98059 on butyrate-induced GADD153 mRNA upregulation. Collectively, these findings suggest that butyrate caused activation of the GADD153 gene at the level of transcription involving mainly the MEK/ERK branch of the MAPK signal transduction pathway. Moreover, these molecular events were not the result of any DNA damage and occurred before several features characteristic of apoptosis became evident.
Insights
Butyrate, a compound that inhibits cancer cell growth, upregulates the GADD153 gene via the MEK/ERK pathway. This occurs before signs of apoptosis and without causing DNA damage.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Butyrate is known to inhibit cancer cell proliferation.
- The early molecular mechanisms underlying butyrate's effects are not fully understood.
Purpose of the Study:
- To investigate the early molecular events triggered by butyrate in colon cancer cells.
- To elucidate the role of GADD153 and the MAPK pathway in butyrate's action.
Main Methods:
- Treatment of HCT-116 cells with butyrate.
- Analysis of GADD153 gene expression using mRNA levels.
- Inhibition of specific signaling pathways (MAPK, MEK) using chemical inhibitors.
- Assessment of DNA damage and apoptotic markers.
Main Results:
- Butyrate upregulated GADD153 expression in HCT-116 cells prior to apoptosis.
- This upregulation occurred independently of detectable DNA damage.
- The MEK/ERK pathway, but not JNK or p38, was involved in mediating butyrate's effect on GADD153 mRNA.
- Actinomycin D attenuated GADD153 mRNA upregulation, suggesting transcriptional regulation.
Conclusions:
- Butyrate induces GADD153 gene activation at the transcriptional level.
- The MEK/ERK signaling pathway plays a key role in this process.
- These events precede the manifestation of apoptosis and are not initiated by DNA damage.
Related Concept Videos
Dysbiosis of the Gut Microbiota
MAPK Signaling Cascades
Microtubule Associated Proteins (MAPs)
GPCRs Regulate Adenylyl Cylase Activity
Two...
Functions of the Gut Microbiota
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...